 |
 |

C-Reactive Protein Concentration and Incident Hypertension in Young Adults
The CARDIA Study
Susan G. Lakoski, MD, MS;
David M. Herrington, MD, MHS;
David M. Siscovick, MD, MPH;
Stephen B. Hulley, MD, MPH
Arch Intern Med. 2006;166:345-349.
Background There is increasing evidence that C-reactive protein (CRP) concentration, a measure of inflammation, is an independent risk factor for the development of hypertension in older adults. However, it is unknown whether a similar relationship exists in younger individuals.
Methods The Coronary Artery Risk Development in Young Adults (CARDIA) study was initiated in 1985-1986 to determine the factors that are associated with coronary risk development in young adults. C-reactive protein concentrations were measured in 3919 African American and white men and women enrolled in CARDIA using blood specimens from the year 7 examination (1992-1993), when the age of the cohort was 25 to 37 years, and the year 15 examination (2000-2001).
Results In unadjusted analyses, CRP concentrations greater than 3 mg/L, compared with those less than 1 mg/L, was associated with a 79% greater risk of incident hypertension (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.40-2.28). However, CRP concentration did not predict risk of incident hypertension after adjusting for year 7 body mass index (BMI) (OR, 1.14; 95% CI, 0.86-1.53) or year 7 BMI and other potential confounders (OR, 1.13; 95% CI, 0.83-1.52). In addition, year 7 CRP concentration was not associated with change in systolic or diastolic blood pressure after adjusting for BMI (P = .10 and P = .70, respectively). These findings were similar within each of the race- and sex-specific groups.
Conclusion C-reactive protein is associated with hypertension in young adults, but in contrast to the finding in older populations, the association is no longer present after adjusting for BMI.
Author Affiliations: Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC (Drs Lakoski and Herrington); Department of Medicine and Epidemiology, University of Washington, Seattle (Dr Siscovick); and Department of Epidemiology and Biostatistics, University of California, San Francisco (Dr Hulley).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED LETTERS
C-Reactive Protein Is an Intermediate Step Between Obesity and Hypertension
Ana Azevedo and Henrique Barros
Arch Intern Med. 2006;166(14):1526-1527.
EXTRACT
| FULL TEXT
C-Reactive Protein Is an Intermediate Step Between Obesity and HypertensionReply
Susan G. Lakoski, David M. Herrington, David M. Siscovick, and Stephen B. Hulley
Arch Intern Med. 2006;166(14):1527.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Systemic inflammation and lung function in young adults
Hancox et al.
Thorax 2007;62:1064-1068.
ABSTRACT
| FULL TEXT
Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women
Sesso et al.
Hypertension 2007;49:304-310.
ABSTRACT
| FULL TEXT
C-Reactive Protein Is an Intermediate Step Between Obesity and Hypertension--Reply
Lakoski et al.
Arch Intern Med 2006;166:1527-1527.
FULL TEXT
C-reactive protein is an intermediate step between obesity and hypertension.
Azevedo and Barros
Arch Intern Med 2006;166:1526-1527.
FULL TEXT
|